Recent perspectives in clinical development of malaria vaccines

Malaria vaccine research has progressed significantly, with RTS,S/AS01 and R21/Matrix-M receiving WHO endorsement in 2021 / 2023. These vaccines show promise, but challenges like vaccine adherence, strain variation, and resistance persist, highlighting the need for more effective, broad-reaching interventions.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-04-15
DOI
https://doi.org/10.1038/s41467-025-58963-4
Citations
14
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
26.30

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent perspectives in clinical development of malaria vaccines

Vasso Apostolopoulos, Magdalena Plebanski, Jack Feehan
14 citations
Nature Communications
Malaria Research and Control
26.30
article

Recent perspectives in clinical development of malaria vaccines

Vasso Apostolopoulos, Magdalena Plebanski, Jack Feehan
article en
14 citations

Abstract

Malaria vaccine research has progressed significantly, with RTS,S/AS01 and R21/Matrix-M receiving WHO endorsement in 2021 / 2023. These vaccines show promise, but challenges like vaccine adherence, strain variation, and resistance persist, highlighting the need for more effective, broad-reaching interventions.

Nature CommunicationsVol. 16(1)
MIT University (MK), RMIT University (AU)
RMIT University
Good health and well-being
Openalex Percentile: Top 0%
Malaria Research and Control
26.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.